- In August 2021, Medtronic updated its HawkOne Directional Atherectomy System, originally launched in 2015, to strengthen its position in the global atherectomy devices market. The FDA-approved application update enhanced the device’s capabilities, contributing to increased adoption and reinforcing Medtronic’s competitive edge in the sector
Frequently Asked Questions
Companies such as Koninklijke Philips N.V. (Netherlands), Medtronic (Ireland), Abbott (U.S.), Boston Scientific Corporation (U.S.), BD (U.S.), Biomerics (U.S.), Catheter Precision Inc. (U.S.), Avinger (U.S.), Cardinal Health (U.S.), Terumo Europe NV (Belgium), and Minnetronix Medical (U.S.) are the major companies in the atherectomy devices market.
In August 2021, Medtronic updated its HawkOne Directional Atherectomy System, originally launched in 2015, to strengthen its position in the global atherectomy devices market.
The countries covered in the atherectomy devices market are U.S., Canada, Mexico, Germany, France, U.K., Italy, Spain, Russia, Turkey, Netherlands, Switzerland, Austria, Poland, Norway, Ireland, Hungary, Lithuania, rest of Europe, China, Japan, India, South Korea, Australia, Taiwan, Philippines, Thailand, Malaysia, Vietnam, Indonesia, Singapore, rest of Asia-Pacific, Brazil, Argentina, Chili, Colombia, Peru, Venezuela, Ecuador, Uruguay, Paraguay ,Bolivia, Trinidad And Tobago, Curaçao, rest Of South America, South Africa, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, rest of Middle East and Africa, Guatemala, Costa Rica, Honduras, EL Salvador, Nicaragua, and rest of Central America.
